>> reporter: case in point another from astrazeneca. it was scheduled to enter trials when the study was halted last month because of an illness. a second patient reportedly suffered neurological problems. at stanford, dion lim, abc 7 news. >>> the astrazeneca trial is still on hold in the united states. as for stanford it says it has several other potential vaccine trials in the pipeline with pfizer. >>> if you're looking to pay less in rent you may be interested in three bay area counties seeing the largest drop in rents nationwide. a new report from realtor.com says rents for a two-bedroom apartment in san francisco plunged more than 21% year to year. the median rent for a two bedroom is just more than $3,900. the report says most big cities are seeing a drop in rents while outlying areas are experiencing an increase. cloud storage company drop box

that from astrazeneca. more than a month after it was paused. ♪ oh, oh, oh, ozempic®! ♪ (announcer) once-weekly ozempic® is helping many people with type 2 diabetes like emily lower their blood sugar. a majority of adults who took ozempic® reached an a1c under 7 and maintained it. here's your a1c. oh! my a1c is under 7! (announcer) and you may lose weight. adults who took ozempic® lost on average up to 12 pounds. i lost almost 12 pounds! oh! (announcer) for those also with known heart disease, ozempic® lowers the risk of major cardiovascular events such as heart attack, stroke, or death. it lowers the risk. oh! and i only have to take it once a week. oh! ♪ oh, oh, oh, ozempic®! ♪ (announcer) ozempic® is not for people with type 1 diabetes or diabetic ketoacidosis. do not share needles or pens. don't reuse needles. do not take ozempic® if you have a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or if you are allergic to ozempic®. stop taking ozempic® and get medical help right away if you get a lump

astrazeneca's vaccine is a viral vector vaccine. what i've learned is the fda has asked for more research and data on previous studies of viral vector vaccines to try and see if there's any association between this adverse event and viral vector vaccine. this is important to assure safety, but most importantly, confidence during this turbulent race for a vaccine. >> when it comes to covid-19, researchers are warning the transmission risk is "rapidly increasing" across much of the northern u.s., from the pacific northwest to the midwest and northeast. what's to blame here? >> so it's very concerning, to be honest with you. as an emergency fith that has worked during the height of the pandemic in the middle of new york city, i fear that we're going to have a repeat of exponential growth. and for context, many public health officials are advising significant mitigation efforts for any area that exceeds 5%. states like wisconsin and south dakota are exceeding 20%. so these predictions are a warning from science that we must act now. >>

al regresar en noticias telemundo muere un voluntario en las pruebas de vacunas de oxford y astrazeneca en brasil, pero los ensayos clínicos no se detienen. >>> miles de colombianos inundan las calles en el paro nacional contra la violencia y la desigualdad social. >>> todo puede pasar en el último y más decisivo cara a cara >>> ¿quién se llevará el voto 5g ya está aquí. con el iphone 12 y el iphone 12 pro en verizon 5g. me encanta el teléfono. el color está muy lindo. it's the best thing ever. ¡wow! con la cobertura, 5g nationwide. y en más y más ciudades, el performance de ultra wideband. el 5g más rápido del mundo. you can get our fastest speed ever. ordena hoy y obtén un iphone 12 por nuestra cuenta al cambiarte. i can't believe this phone is out and it's amazing. es el mejor momento para cambiarte a verizon. ¿la próxima vez prueba bounce awrinkle guard. la primera hojita mega con 3 veces más relajantes para arrugas. la camisa de wrinkle guard tiene menos arrugas y estática, y más suavidad y frescura*. combate las arrugas con bounce wrinkle guard! ¡manchas meno

astrazeneca has been given the green light to resume. the pharma giant paused the trial in early september after a participant in the uk fell ill meanwhile johnson & johnson is set to resume its trial today after a patient in its trial also got sick. the vaccine did not cause the volunteer's illness it was determined >>> the u.s. sets another record in daily coronavirus cases, and another white house break out, this time involving the vice president. we'll have more after the break. >>> your headlines, shares in sap plunged to the bottom of the dax, the worst decline since 1992, wiping out $32 billion in market cap after the german software firm scrapped its 2020 outlook. >> as the ceo i have to be focused on the long term value of this company, so i cannot equate the success of our customers and the significant revenue of sap >>> stocks set for the worst session since march, oil and travel impose steep losses italy's new virus restrictions on bars and restaurants and gyms >> translator: if i were on the other side today i would certainl

the stock is down more than 7% today offer earnings. >>> a news alert on astrazeneca. meg tirrell with more. >> the fda has now given the green light for astrazeneca to resume it is covid-19 vaccine trials here in the united states we have been hearing hints of this for the last week now it is official the company saying the fda reviewed all safety data from trials global reand deemed it was safe to resume the trill the company includes results from the late stage trials are expected later this year depending on the rate of infection in the areas where the trials are being conducted this was likely to happen based on sources who also told the journal that the fda didn't find that the vaccine was responsible for the two neurological cases though the journal reported it couldn't rule out a link either. the company not giving any information further than just saying the fda reviewed the safety data and concluded it was safe to resume the trial guys, we have been hearing that in j&j's trial, which is also on pause, is likely to be resumed soon as well we don't have confirm

viviana: de otra parte, la noticia alentadora frente al virus es la vacuna que desarrollan astrazeneca y la universidad de oxford, que parece estar dando buenos resultados. las pruebas muestra que funcionan en adultos mayores de 56 aÑos con mÍnimos efectos secundarios. >> estaba una de astrazeneca ha demostrado que puede causar anticuerpos. lo bueno es que estÁ causando eso en personas mayores. viviana: mientras la vacuna llega, las autoridades de salud dicen que seguirÁn existiendo hasta el cansancio que lo mejor es practicar el sashimi social, usar el tapabocas y lavarse frecuentemente las manos. patricia: en el paso, texas estÁn experimentando un rebrote de coronavirus que estÁ colapsando al sistema hospitalario. el incremento en los contagios es tan alto, que las autoridades dispusieron un improvisado centro de salud en la calle para enfrentar la emergencia. un toque de queda fue decretado mientras se normaliza la situaciÓn. marÍa: los hospitales de el paso, texasestÁn tomando medidas extremas. instalaron carpas para atender el flujo de pacientes contagiados de coronavirus

secretary azar: you broke up of it -- i believe the question was about the status of the astrazeneca vaccine trials. as of now in the united states unless something has changed, the astrazeneca trial remains on clinical trial hold in the united states because of the of the companyda as to a possible serious adverse event. as a company as well as the fda is examined the data to determine, is there a connection to the vaccine, would , there is a causative connection and if so, should the trial be restarted or continued or are there other precautions one should take. one is to modify the consent forms, anything about the that.ol, that's part of the fda has been working to gather information from astrazeneca to assist in that evaluation. as far as the process, it is continuing as we speak and that will be a determination made by the fda. one more. yes. can we see who is on the phone? >> could we have on the phone? we have thoughts on the phone? >> secretary azar, thank you for taking our questions today. the president of the united states has held numerous rallies across the country, in

brazil volunteer in the astrazeneca volunteer trial has died. it is the one volunteer in in the astrazeneca trial has died. we will see exactly what it was that contribute it to the death and whether it was as a result of the treatment. meantime, house speaker nancy pelosi sounding and optimistic tone about stimulus talks, saying she is pretty happy about the state of the negotiations and said i think we have a prospect for an agreement. we are joined by laura davidson. the question is not whether they can get there, it's a question of whether nancy pelosi wants to get there and mitch mcconnell wants her to get there. house andth the white house democrats projecting a lot of optimism today. we have had a lot of optimism in the weeks leading up to this and there has not yet been a deal. even if steve mnuchin and mark meadows, the white house chief of staff, can cut a deal with nancy pelosi, that need to pass through the senate. assuming all democrats can vote for, they still need 13 republicans to agree. that what steven mnuchin and nancy pelosi

the fda has been working to gather data and information from astrazeneca to assist in that evaluation. as far as the process, it is continuing as we speak and that will be a determination made by the fda. one more. yes. can we see who is on the phone? who do we have on the phone? >> fox. >> do we have fox on the phone? >> secretary azar, thank you for taking our questions today. the president of the united states has held numerous rallies around the country, many in the hottest of hot spots many with no social distancing and mask wearing. the president also says we are rounding the corner. in simple english, sir, are we rounding the corner and or these rallies a good idea? the second part, the president has been critical of dr. fauci lately. what impact do you believe as -- this will have as your department tries to distribute and convince americans to take a vaccine that many surveys are showing some americans are skeptical about or concerned about taking? our guidance is the same regardless of setting. wash your hands, watch your distance, avoid settings where you can't do those thi

luis: la vacuna de astrazeneca y la universidad de oxford es una de las que vamos adelantada. ramÓn: vamos a saber cómo estarÁ el tiempo para los Últimos dÍas de octubre. ppasamos con suheily lÓpez belÉn. nos llene el reporte completo del tiempo. suheily: buenas noches, el evento de vientos que detectamos esta madrugada en el Área de la bahÍa fue mÁs fuerte del aÑo 2020. en las prÓximas dos semanas nos estÁ esperando un evento de viento similar o significativo. las rÁfagas fueron significativas en el condado sonoma, 89 millas por hora. en sectores de santa elena con el oeste de la regiÓn, 82 millas por hora, 66 millas por hora. en south alito y cerca de la 55 millas por hora. los vientos irÁn disminuyendo. las temperaturas se vieron bastante agradables. san josÉ en 76, o plan en 80, santa rosa en 80. a pesar de que tenÍamos 80 como mÁxima, los vientos permitÍan que se sintiera mÁs agradable. fueron temperatura sobre lo normal, ya que lo normal son 71. madrugada del martes templada en gran parte de la regiÓn, con mÍnimas en los bajo mediados 50. esa chama

this is one of the volunteers in the experimental coronavirus trial, astrazeneca in brazil. we hear this death occurred on monday that the public health agency now just alerting other people to this death, but also saying at the same time, brianna, that the trial will continue. it's not clear, at least initially when you hear these reports of deaths exactly what happened, other even if the person received a vaccine or received a placebo. when you're dealing with tens of thousands of people in these trials, the point they're making is sometimes the deaths can occurred even for reasons unrelated. the fact they're continuing the trial may be a bit of a clue, but still we're getting more details. you may remember, this is now the third time we've had some sort of adverse effect, reported, not clear if it was due to the vaccine, but back in july, the astrazeneca trial was paused briefly, and about six weeks ago, you may remember it was a person who developed these neurological symptoms at that point, difficulty with walking, these sort of symptoms that were suggested that maybe t

so it may push out the dates, possibly >> would you have imagined that the astrazeneca program would be running every else in the world xecht t except the united states right now? >> i haven't thought about it. i haven't tried to imagine that. >> it means that it will be harder for the astrazeneca program to become available here in the united states in any kind of similar time line that is the point. >> okay. johnson & johnson is due it report earnings around 6:45 eastern and we'll bring you the interview with the company's cfo shortly after that report. >>> meantime disney shares are getting a pop this morning, the company reporting a new restructuring plan for its media and entertainment divisions putting more emphasis on streaming. they will central liz the media business into a single organization responsible for the content, distribution, sales and also of course the disney plus streaming service. here is bob chapek speaking yesterday on "closing bell." >> i would not characterize it as a response to covid i might say that covid accelerated the rate at which we made the transit

reporter: astrazeneca announced the vaccine it is developing in partnership with the university of oxford produce as similar immune response in young and older adults. this increases hopes the world will have a safe and effective vaccine before the end of the year however dr. anthony fauci cautions that the first doses will be limited and prioritized for health care workers and high-risk individuals. the general public may have to wait until the second or third quarter of 2021 until we start to see shots going into our arms. connell, back to you. connell: thank you, jonathan serrie in atlanta. in the midst of all this, it was a busy day on the campaign trail for president trump. check in with blake burman live on the white house north lawn. blake. reporter: three different stops in the state of pennsylvania for president trump. this state could be crucial for his re-election and here is why. 20 electoral votes are up in the state. democrats won six elections from 92 to 2012. he won by just una percentage point. when you look at "real clear politics" average, potentially joe biden up by a

we're told by astrazeneca theirs is mandatory. the fda put them on a mandatory hold so that's different. this one has only gone on for a week. the one for astrazeneca was announced september 9th. it's been more than a month they've been on hold and a mystery why it's taking this long for the fda to decide do we let the trial continue or sorry, this trial can't continue. they had two participants that developed neurological illnesses, astrazeneca did. let's look at all four trials that are currently in the united states so there's johnson & johnson and astrazeneca, which are both on pause, and then there's pfizer and moderna. those started july 27th. those are still up and running and they have both said they think they could have some data for the fda to look at towards the end of next month. erica? >> elizabeth, thank you. >>> a disturbing new video releaseed apeers to show at least one suspect involved in an alleged plot to kidnap michigan's governor in field training exercises. here's john avlon with your reality check. >> it's

astrazeneca giving us a statement saying it is encouraging to see immunogenicity responses were similar between older and young adults they say these results further build the body of evidence for the safety and immunogenicity of astrazene astrazeneca. pfizer from its phase three trial and that depends on a lot of things including the rate of infection in the trial and, guys, how well this vaccine works. so, we'll wait to see. >> meg, two things one, did the administration ever correct the president's, i'd say, boastful comment during the last debate about j&j is the closest to finishing given the fact that they were on hiatus. second, where are we the president was touting the regeneron. where will we get the therapeutic product and what we are having is a decline in death and regeneron could be the key company at this moment >> yeah, its a's going to be limited for the antibody drug. enough for 50,000 people if they got the emergency use authorization now. they expect to bring that up to 300,000 within the next few months give on the number of people being diagnosed daily with covid-1

let's look at an astrazeneca statement. what they had to say is serious adverse events, a fancy way of a participant getting sick are not uncommon in clinical trials. the number of adverse events can be expected to increase in trials involving large numbers of participants. what they're trying to say, this is from johnson & johnson, what they're trying to say is look, when you vaccinate a bunch of people, including in trials, someone is getting sick. if there's any thought the sickness might be related to the vaccine, they pause the trial. we are told by experts this doesn't happen that often. it happens, but is not how most trials go. most trials don't have pauses. certainly when you see an illness that could be caused by the vaccine, right thing to do is pause the trial. >> and elizabeth, confusion there, easy to understand. this is johnson & johnson. the mix-up is astrazeneca had to do the same in its trial. what's the status of the other vaccine trials? >> exactly. i was talking about johnson & johnson. there are four t

. >> thursday volunteers in san francisco will begin getting vaccinated in phase three trails of astrazeneca's covid-19 vaccine. the entire study was put on hold worldwide in september after a participant in the uk got sick. dr. susan says it wasn't a bad setback. >> we're also really pleased that the usual checks and balances built into a particular study were actually being effectively used. after a thorough review by the fda, the company now says it is safe for the trial to resume. in the area, they expect about 500 participants. and despite the delay, she says she has not lost confidence. >> it's to be expected. that's going to happen in any trial. that doesn't mean it was the vaccine that caused the illness. >> as for when the vaccine may be available, other companies are further along, but the astrazeneca could be out for limited distribution sometime early next year. >> all week here on abc 7 we're looking at the new way to holiday, how things will be different this year because of the pandemic. the rush on essential products like hand sanitizer and wipes has eased. >> but ama, there is

. >> thursday volunteers in san francisco will begin getting vaccinated in phase three trails of astrazeneca's covid-19 vaccine. the entire study was put on hold worldwide in september after a participant in the uk got sick. dr. susan says it wasn't a bad setback. >> we're also really pleased that the usual checks and balances built into a particular study were actually being effectively used. after a thorough review by the fda, the company now says it is safe for the trial to resume. in the area, they expect about 500 participants. and despite the delay, she says she has not lost confidence. >> it's to be expected. that's going to happen in any trial. that doesn't mean it was the vaccine that caused the illness. >> as for when the vaccine may be available, other companies are further along, but the astrazeneca could be out for limited distribution sometime early next year. >> all week here on abc 7 we're looking at the new way to holiday, how things will be different this year because of the pandemic. the rush on essential products like hand sanitizer and wipes has eased. >> but ama, there is

astrazeneca resume their trial. they are on positive the us. as fate would have it this morning j and j will be reporting earnings at the 6 am our eastern time, full coverage at foxbusiness, putting new 8 and new focus on those earnings. todd: that is the business perspective. on the medical perspective it is important to note this is the checks and balances in these studies that people don't get sick. thank you. jillian: brain kilmeade with what is coming up on "fox and friends". good morning, how are you? brian: we will talk about what is coming through the morning and afternoon in the next few days. senate judiciary committee gearing up for day 2 of judge amy coney barrett's confirmation hearing, they talked around her, not to her, two republican senators, john kennedy and turner phrase like no one else and marsha blackburn on what they expect today. also on deck, senators tom cotton and newt gingrich on the most important election since 1860. democrats coming to the offensive the affordable care act, that this would nomination would be the

the fda has cleared drugmaker astrazeneca to resume the trial of its experimental coronavirus vaccine. it has been on hold since last month, after a volunteer in the uk became ill. the trial had already resumed in other countries. astrazeneca is one of four companies that started late stage phase 3 trials in the u.s. >>> parents are calling on san francisco schools to put politics aside and open schools for in person learning. today, had both parents and students held a rally in front of the school district's office, and they plan to hold these rallies, three times each week. parents claim the district and board are not focused on the right priorities. they want to work together on a reopening plan. >>> we want to work with the board of education, so they should not be an us versus them kind of conversation. this should be about how it all comes together in this pandemic. to solve problems. and make sure kids are taking care of. >> reporter: they plan to reopen for in person learning for some students starting in january. that include students with special needs, preschool students, k

last month astrazeneca temporarily stopped its trial after a patient was diagnosed with a neurological condition. >>> meanwhile, the mayor of manchester, tennessee, died from coronavirus. lonnie norman died. he was 79 years old. now his death comes as new cases of covid are on the rise in 39 states. average daily deaths are also going up in ten states compared to two weeks ago. one of the hardest hit spots is the midwest. adriana diaz reports from chicago. >> reporter: with the nation seeing nearly 50,000 cases today, an ominous warning from public health officials. >> we are truly headed into the fall with a could he video individual virus disaster on our hands? >> reporter: seeing roughly twice as many cases as the spring. >> i hope these numbers jolt the american public into the realization it's on a trajectory of getting worse and worse. >> reporter: are we still in the first wave or is this the second wave? >> i don't believe this infection is being transmitted in waves. what it is, it's more like a coronavirus forest fire where, in fact, it burns, burns, burns. as soon as you let

a volunteer in astrazeneca vaccine study in brazil has died. it's not clear whether the person received the vaccine or placebo shot and further information is not being disclosed because of medical privacy. the trial however will continue. astrazeneca late stage clinical trial is on hold here in the u.s., but is expected to resume as soon as this week. >>> a daring cliff rescue early this morning in san francisco's presidio. emergency crews got the call about 1:30 a.m. a man was marooned on the rock just below the battery crosby trail. rescuers had to use swimmers, a boat, land crews and helicopter just to get the man back to shore. >> there's an area that gets close to the cliff, but there's wooden markers and i can imagine people climbing over where you see the woodens posts and that's where things get dicey. >> the whole rescue took three hours. the man is in the hospital with hypothermia, cuts and scratches. park officials don't know how or why he was out there in the middle of the night, but they are working with him to get some answers. >

astrazeneca says there are no concerns about continuing the study in brazil. it is a phase three clinical trial in the u.s.-- i should said its trial here in the u.s was put on hold last month after a volunteer in europe developed neurological symptoms. and there's breaking news tonight that expands who's at risk for being infected with coronavirus. the c.d.c. says it is changing what it defines as close contact with someone who is sick. the new guidance says close contact means being within six feet of an infected person for a total of 15 minutes, even when those 15 minutes are spread out fer a full day. now, that change comes as almost every state in the u.s. is seeing a surge in new covid cases. tonight, in a cbs news exclusive, adriana diaz is inside wisconsin's largest hospital where the situation is dire. >> reporter: there are five covid units at aurora st. luke's medical center in milwaukee. this i.c.u. is for the most critical. nurse ashley bonus has been here since the start. >> you look great! >> reporter: treating patients, like 73-year-old attorne

if you can't afford your medication, astrazeneca may be able to help. astrazeneca may be able fraudsters, they're out to get your medicare number so they can bill fake claims in your good name. don't give them that chance. just calling to confirm your medicare number. do you have your card available? for example, if the caller says they're from medicare, watch out. it's probably a scam. don't give out your card number. and always check your claims statements for errors. report fraudulent charges to 1-800-medicare. guard your card. learn more at medicare.gov/fraud. straining, and bloating, again and again. no way. more exercise. more water. and more fiber is the only way to manage it. is it? maybe you think... it's occasional constipation. maybe it's not. it could be a chronic medical condition called ibs-c, and time to say yesss! to linzess. linzess works differently than laxatives. it helps relieve belly pain and lets you have more frequent and complete bowel movements. do not give linzess to children less than six and it should not be given to childre

astrazeneca trials started, phase three trials started on the 31st. the pause on the 9th, didn't go on very long. it wasn't until the week of october 5th, a month later, that astrazeneca got their safety data to the fda according to this source. i was speaking to a former commissioner of the fda. he said, look, this is going to take a while potentially. the fda is going to have a lot of questions. two volunteers have become sick. they have developed neurological symptoms, both of them. that's a red flag. when you see there are the same kinds of symptoms in more than one volunteer, that is a red flag. the fda is going to have a lot of questions. jake. >> that's why we don't listen to politicians that want a vaccine released before an election for political reasons when there's safety measures to be taken. thank you very much. >>> close to 18 million people tested positive, just as many thrown into poverty since this began. that shocking number next. (vo) businesses are always making choices. here's a choice you don't have to make: the largest 5g networ

astrazeneca, meanwhile, just got the green light to restart their trials here in the u.s. after a similar situation. but here's the thing. as the director of the national institute of health said today, unless enough of us take that vaccine, then this virus could be here for years. we are now in the full surge. virus spread, accelerating. >> we're in a very serious moment right now. we're seeing increases in cases. and what we're seeing is through the midwest, upper midwest and the plains, a lot of cases occurring. >> a dozen states are suffering all time record high. average daily case counts. >> we're rounding the turn. we're rounding the corner, it's going away. >> the truth of the matter is that we're turning the corner into a tsunami. >> reporter: nationwide, the three worst days for new cases were all back in ugly, ugly july. coming in 4th yesterday. 71,671 new infections. >> this time it's in the middle of the country. >> reporter: and the number of covid patients in our hospitals has soared by a third in just three weeks or so. >> then we'll see results from that.

astrazeneca strikes a deal with the u.s. government and do downplays president trump's treatment saying large studies are ongoing. >>> a lot of earnings in the week ahead bank earnings first. apple's big phone launch and amazon prime day and the retail impact from that and what it is actually going to mean for the stocks that you own. carl >>> jim, this morning i heard you talking with andrew a moment ago. growing sense is we keep an eye on stimulus talks that maybe the market really has focused on the front burner more talk about antibodies and we're going to hear what len told cbs in a few minutes. >> if you didn't know, carl, and you read the research this morning it's almost like they got in a room and they said you recommend facebook and you talk about amazon and it's your job to talk about alphabet it's a concerted effort not a national conspiracy but a concerted effort to take up every one of those whether it be amazon prime and the big 5g day for apple. but you take a look at like a microsoft comment and what's a mic

astrazeneca is on hold right now. we're just paying a lot more attention to all of these programs in the middle of this pandemic guys >> so to recap, we have two vaccine trials paused, astrazeneca's and johnson&johnson's just last night. this one was for a treatment we had the news last week that eli lilly was fast tracking its covid treatment this is this that same treatment or a different one be and how many different treatments are they working on >> it is the treatment that elie lili has filed for an emergency order for use in is a trial that was paused in hospitalized patients with covid-19 but it is the same antibody. now, you are right that johnson & johnson's clinical trial and vaccine was paused last night as they investigate an unexplained illness and astrazeneca's trial has been and clinical hold, a stronger, more regulatory situation. as they continue to investigate that safety event. that trial has restarted in other countries, not yet in the united states. and so we're going to try to get more informatio

astrazeneca was also paused for the same reason but both trials have resumed. in fact this week researchers in the astrazeneca trial with oxford say their vaccine has shown to have a strong immune response in elderly people. and moderna says by the end of this year it expects to have approximately 20 million doses ready to ship in the u.s. though it's still in stage 3. >> projections that we have that i i think and hope will be reasonably accurate that we will know some time in december whether or not we have a safe and effective vaccine. and practically speaking when will we be able to deploy that vaccine. >> reporter: people in the stanford trial will take a phone survey every week to see if they have symptoms. dr. grant says they still need more volunteers. >> right now we're doing the young healthy individuals and older healthy individuals. if you don't fit that category we will later call you once we've moved onto people with chronic conditions. >> each will be monitored periodically over two years, but the data on if it works will come much sooner. ian cu

yesterday we heard about the astrazeneca trial, a participant died, this was in brazil, i think. talk about what is new in the vaccine world. >> i think that headline is actually getting a lot of attention. people are scared about it. you know, astrazeneca did acknowledge that somebody died, but they're continuing with their trial. they haven't released a lot of data about the death but it's presumed it doesn't have to do with the actual vaccine and that it's kind of independent of what's happening in the trial. but we're still kind of in an unprecedented territory with how many vaccine manufacturers are actually pushing forward. there's 11 right now in phase 3 trials. the two leaders, if you will, the ones who are farthest along, moderna and pfizer. the fda said we need at least two months of safety data, so even mod concern that who enrolled 30,000 volunteers, openly said they're not going to put out data and go for authorization in the late november, early december. still breakneck scientific speed, but don't expect a vaccine until late this year, and that doesn't mean that ev

. >>> after pushing for more than a month astrazeneca and johnson & johnson are starting covid vaccine trials again. johnson & johnson put a trial on hold last week after a participant got sick. today the company said it found no evidence the vaccine caused the illness. astrazeneca paused its trial last month when a participant developed a spinal cord injury after receiving the vaccine. the two companies rejoined in late stage clinical trials in the u.s. >>> covid-19 is front and center on the campaign trail as well. joe biden's first post debate event was a speech devoted to the pandemic. he blasted president trump for quitting on any serious attempts to battle the virus. >> president trump said we're rounding the corner, it's going away, we're learning to live with it. they have quotes. but as i told him last night, we're not learning to live with it. we're learning to die with it. this is a dark winter ahead. >> the democratic nominee says he plans to implement an aggressive science-based plan to fight covid with a goal of shutting down the virus, not america. >>> back-to-back ralli

if you can't afford your medication, astrazeneca may be able to help. latonight, silence it with newd byzzzquil night pain. astrazeneca may be able because pain should never get in the way of a restful night's sleep. new zzzquil night pain. silence pain, sleep soundly. >> o'donnell: and tomorrow, on the "cbs evening news," we'll speak with dr. anthony fauci about the fall coronavirus surge and the government's response. you can text me your questions at 2022171107. and a reminder: if you can't watch us live, don't forget to set your dvr so you can watch us later. that is tonight's edition of the "cbs evening news." i'm norah o'donnell in the nation's capital. wool soo you right back here ♪ ♪ >> announcer: this is the "cbs overnight news." >> i'm kris van cleave in washington. thanks for staying with us this morning. the worldwide effort to get a coronavirus vaccine to the public has hit another snag. johnson & johnson paused its phase three trial after a participant developed an unexpected illness. the company hasn't confirmed if that illness is rel

. >> reporter: on russian state tv cribedonth, they described the the oxford-astrazeneca vac oxford-astrazeneca vaccine as a monkey vaccine, portrayed as downright dangerous. propaganda spreading fear about the vaccine has also shown up on the internet, pushed by russia, according to a new investigation by the "times" of london. >> the more we fight amongst ourselves, whether it's about issues of race or issues of science, the more putin has a free hand. >> reporter: the russian government denies any involvement, but experts say it's right out of vladimir putin's playbook. a u.s. study found that the same russian trolls that american intelligence says meddled in the 2016 election also tried to inflame a debate over the safety of vaccines. it seems to have worked in ukraine, a country fighting a war against russian-backed separatists, where vaccine disinformation has already been lethal. a measles outbreak has infected more than 100,000 people. ulana suprun was ukraine's acting health minister when the measles outbreak began, which she blames partly on russian lies. ukraine's vaccination rate re

if you can't afford your medication, astrazeneca may be able to help. latonight, silence it with newd byzzzquil night pain. astrazeneca may be able because pain should never get in the way of a restful night's sleep. new zzzquil night pain. silence pain, sleep soundly. >> o'donnell: and tomorrow, on the "cbs evening news," we'll speak with dr. anthony fauci about the fall coronavirus surge and the government's response. you can text me your questions at 2022171107. and a reminder: if you can't watch us live, don't forget to set your dvr so you can watch us later. that is tonight's edition of the "cbs evening news." i'm norah o'donnell in the nation's capital. ♪ >> cbs sports welcomes you to the following presentation of the national football league. ♪ ♪

astrazeneca provided the information and data it needed for the updated review. with the fda giving a green light to continue in that clinical trial tells me they are going to continue watching and monitoring closely for any similar events such as what they have seen already. however, the fda must be comfortable that either the event was rare or unsignificant for whatever they investigated and/or the company has a really strong plan in place to monitor for that to happen again. if it does, i'm sure the fda will be notified very quickly. i'm encouraged that the trial is continuing. i'm encouraged that we have five or six other clinical trials also in late stage development. so i think we are getting closer and closer to a vaccine. >> on the other hand, you heard what dr. francis collins, the national institutes of health, is warning if only 50% of americans are willing to go out there and get the coronavirus vaccine and god willing there will be a safe and effective vaccine either one dose or two doses, whatever it takes, the virus could still stick around for yea

we have a news alert on astrazeneca. we were just speaking about the progress of various vaccine trials and now the fda told astrazeneca it can restart its covid-19 trial in the u.s. it wraps up a week-long examination of two issues that emerged in the trial astrazeneca is higher by about 0.6% as it's given the green light to renew phase three trials >> we were just talking about it with meg there a couple of minutes ago. she saw that as a stumbling block but also sort of predicted they would give them the go-ahead at some point to move forward. anyhow, the candidates bickering last night over cash the president saying that joe biden takes more of it from wall street, even though he got into that game, he could outraise biden in an instant. eamon javers has the fund-raising facts >> the president is certainly right about one thing, which is that joe biden has more wall street money than donald trump does not clear whether donald trump could outraise biden if he so call chose to try to do that take a look at the big numbe

is it unusual that astrazeneca hasn't been more forth coming? should we know why there's this long pause? >> well, the pause is pretty common. pauses like this happen all the time in clinical trials. and the first thing i would say is that this is evidence that the fda oversight process is working. that they're doing the deep investigation that is necessary. you know, people might argue that while we generally don't share the details around these things and i understand that, i've actually been calling for more transparency and i've been saying these are really unprecedented times and they need unprecedented transparency. so i do think without revealing any patient information that we should know more information. but, this is pretty common for how clinical trials run. >> look. it would be good to get more of the science, the transparency there and hear from the scientists involved rather than the executives from the companies involved. the ones who are maybe most concerned about making money or as concerned or at least concerned about making mo

the ukjust really hoping the astrazeneca trial would be very fruitful because in terms of being a world leader, as we leave the eu a big deal to have that on uk shores. however it looks like pfizer could be slightly ahead in germany. this will be a big deal. one of six drugs but reports the government have managed to get early access to. if you think of this as gaming the system and with the government have done is putting money into different vaccines saying we wa nt money into different vaccines saying we want to have a decent sized batch, this vaccine is 20 million doses but you need to doses of the vaccine. and with that there were only do 10 million people. next to last very long but it may well provide some relief to the much more vulnerable people. however can we do know in light of previous vaccines we have seen the big challenge is making sure that the people are convinced that it is safe to take. everyone is looking for some optimism around this. and we have heard probably a lot more in the british press about the oxford vaccine, and so i think there will be cheering to hear t

. >>> a volunteer in brazil's trial of astrazeneca covid-19 vaccine trial has died according to health officials. it's not clear whether the volunteer received a vaccine or a placebo as part of the trial, and why the person died. no more information was released due to privacy concerns. astrazeneca said nothing happened to justify stopping or pausing the test, so the trial in brazil will continue. and here in the u.s., a top health official says astrazeneca and johnson & johnson may soon be able to resume their vaccine trials. they had been placed on hold in the united states because of illnesses among volunteers. >>> well, a new cnn poll shows a tight race between president trump and joe biden in the key battle ground state of florida. more on cnn's latest polling just ahead. is that where we're from? well, actually...we're from a lot of places. you see we're from here and there and here... your family's story is waiting to be shared. at ancestry.com the lack of control whenover my business kai, made me a little intense. but now quickbooks helps me get paid, manage cash flow, and run

this on the heels two weeks ago, astrazeneca was in the same kind of conundrum. different reasons here. does it give the markets pause? speaking totally about market response, that it is going to be a tough for a vaccine to be out this year? you know, really have, what 10 weeks left? that looks unlikely? >> yeah. i think, neil, i think it is almost impossible. i think the market is representing that. things that are not going to respond well at all until you get a vaccine. you will have cruise lines, hotels, airlines, theater chains, they will not do well until people feel comfortable being in mass gatherings traveling with a large group of people where social distancing is not possible. you will not have those move until you see some type of a vaccine. pfizer had a vaccine study coming out october 14th. approximately when the third phase trial is ending. first phase you had antibodies double what you had for people who had coronavirus. that does not mean the third phase trials will be as successful. that is very good news for a vaccine study. even if pfizer come

astrazeneca and oxford university say there vaccine trial will continue, despite the death of a volunteer in brazil. regulators say there are no concerns about the safety of the brazilian trial. russia's president, vladimir putin, said he is not planning to impose any blanket restrictions to contain the pandemic. his comments come as russia reported a record new daily death toll from the virus. tonight, the security situation in nigeria's second largest city appears to be deteriorating with reports of buildings on their, roadblocks, and protesters defying a curfew to demonstrate on city streets. the unrest follows the violent crackdown on protesters. unconfirmed reports suggest 12 people were killed by gunshots at a protest yesterday. [gunfire] >> more shots fired at protesters, and this despite the global outrage following tuesday's shooting of peaceful demonstrators in the nigerian capital. military forces had reacted to protesters defying a curfew by turning the streetlights off and shooting into the crowd, killing and wounding dozens. >> there are those trying to trigger war. it was v

with astrazeneca, still on hold in the u.s. michelle, we are desperate to see this candidate make it over the line. somebody has to get over the line at some point. talking to people in the logistics business, they talk about the incredible complications of getting this distributed. you have to refrigerate most of the chainsnes and are long and complicated. what are you hearing about that? once we get the candidates, how quickly is it going to get out there and how difficult is that process going to be? absolutely ais huge challenge to get these vaccines out to people. many of them not just refrigerated, they have to be frozen at unbelievably cold temperatures and this is an infrastructure that is not really well-established throughout the entire world, certainly not even throughout countries like the u.s. and places like across europe. so we are seeing some of those infrastructure buildings literally buildings and freezers being built right now. that is one of the concerns with johnson & johnson trial being halted. that should

astrazeneca was in the lead with its coronavirus vaccine, on the hold for the past month. that is how much longer it has setback the u.s. johnson & johnson has been on hold for two weeks. it doesn't seem that long, but in the middle of the pandemic, it is harder to bear. shery ahn: what is happening to the vaccine that brazil was supposed to buy? >> they announced they would buy the vaccine, the one being given to students in china traveling to the u.s., and other situations like that, but it has not been fully tested. the president of brazil said he is not on board for having the brazilian people as guinea pigs to see if this will work until they have crossed the finish line and have proven it is safe and effective, so how that will turn out, we are not sure yet. we just don't know when they will start getting the vaccines. what do we see as cases continue to rise? seeing phenomenal increases in europe, going up by 120,000 a day. in the u.s., about 60,000 the day. both numbers are expected to increase dramatically in the coming weeks. hospitalizations and deaths are start

y falleciÓ un voluntario brasileÑo que participaba en ensayos de la vacuna de astrazeneca y la universidad de oxford contra el coronavirus, aÚn no se sabe si recibiÓ la vacuna o un placebo pero las autoridades anticipan que las pruebas seguirÁn, francisco tiene las reacciones. >> no de miedo pero sÍ de pensar que si me pasa a mÍ. >> asÍ fue la reacciÓn de ernesto al enterarse de la muerte de un hombre en brasil voluntario como Él a las pruebas de la vacuna del covid-19 con astrazeneca. >> soy uno de los voluntarios a los que le han puesto una vacuna experimentado y podrÍa ser yo la persona que falleciÓ. >> pero lo que aÚn no se sabe si la vÍctima habria recibido uno vacuna o un placebo, por lo tanto, no hay evidencia que se muerte tenga relaciÓn con la vacuna, mientras la farmacÉutica se revelÓ a revelar detalles del voluntario debido a las clÁusulas de confidencialidad mÉdica. >> ellos pueden saber si le dieron o no la vacuna. >> lo que si estÁ confirmado que la universidad de oxford junto a astrazeneca anunciÓ que tras una revisiÓn del caso en brasil no hay preocupaci

astrazeneca and johnson & johnson those trials are on pause while they look at what's going on, astrazeneca had two people become ill and johnson & johnson one. so they're hoping half of them will have data to show to the fda in mid november. emphasis on might. >> joining us is dr. del rio, always good to have you on. >> good to be with you. >> you heard elizabeth's update on when data would come on. we had dr. paul on in the last hour. approval coming the next couple months, how about broad availability of this? he said not till the middle, end of next year that all of us can be likely to get one. do you agree with that or might it come earlier? >> he's absolutely right. if we have a vaccine, let's assume that everything goes well and we get our vaccine by december, january the first rules of the vaccine -- the first roll out is going to be to first responders, people at higher risk, and then it gets to a tiered approach and getting it to everybody, the last phase, is not going to be until the second or third quarter of next year. the two vaccines that elizabeth was talking about, the pfiz